Rocket Lab is rated as a Speculative Buy even after its Neutron rocket launch was delayed to the fourth quarter. The stock trades at a high premium, reflecting strong investor confidence in its progress and future launch capabilities. The company's backlog surged 69% quarter-over-quarter to $1.85 billion, but sustaining this growth depends on the successful execution and monetization of the Neutron rocket. While improved launch economics and liquidity ease investor concerns, further delays could negatively impact the stock. The key challenge remains validating Neutron's reusability through timely launches.
On December 1, 2025, YieldMax Ultra Option Income Strategy ETF (ULTY) executed a 1-for-10 reverse split, raising its share price tenfold but not increasing investor value. The fund charges a high 1.24% expense ratio, significantly more than comparabl...
YieldMax Ultra Option Income Strategy ETF (ULTY) promises a high annualized yield near 62% through weekly distributions by selling options on volatile tech stocks. However, its total return over the past year was -4.8%, far below the S&P 500's 22% ga...
